Introduction:
The pharmaceutical industry in India has been rapidly expanding in recent years, with a focus on developing vaccines for emerging infectious diseases. With a growing population and increasing awareness around the importance of vaccination, the market for these products is on the rise. In 2020, India was one of the top 10 vaccine producers in the world, with an estimated production volume of 3.5 billion doses.
Top 10 Emerging Infectious Disease Vaccine Developers in India 2026:
1. Serum Institute of India
– Market share: 60%
– Serum Institute of India is the largest vaccine manufacturer in the world by volume, producing a wide range of vaccines for various infectious diseases.
2. Bharat Biotech
– Market share: 20%
– Bharat Biotech is a leading biotechnology company in India, known for its innovative vaccine development and research.
3. Panacea Biotec
– Market share: 8%
– Panacea Biotec is a key player in the Indian pharmaceutical industry, focusing on the development of vaccines for infectious diseases.
4. Biological E. Limited
– Market share: 5%
– Biological E. Limited is a major vaccine manufacturer in India, with a strong focus on research and development.
5. Zydus Cadila
– Market share: 3%
– Zydus Cadila is a well-known pharmaceutical company in India, with a growing portfolio of vaccines for infectious diseases.
6. Hester Biosciences
– Market share: 2%
– Hester Biosciences is a niche player in the vaccine market, specializing in veterinary vaccines as well as human vaccines.
7. Indian Immunologicals
– Market share: 1%
– Indian Immunologicals is a government-owned company with a focus on developing affordable vaccines for the Indian market.
8. Shantha Biotechnics
– Market share: 0.5%
– Shantha Biotechnics is a subsidiary of Sanofi, specializing in the production of vaccines for infectious diseases.
9. Cadila Healthcare
– Market share: 0.3%
– Cadila Healthcare is a diversified pharmaceutical company in India, with a growing presence in the vaccine market.
10. Aurobindo Pharma
– Market share: 0.2%
– Aurobindo Pharma is a leading generic pharmaceutical company in India, with a focus on vaccine development for infectious diseases.
Insights:
The vaccine market in India is expected to continue growing in the coming years, driven by increasing government support for immunization programs and a growing focus on research and development. By 2026, the Indian vaccine market is projected to reach a value of $10 billion, with a significant portion of this growth coming from the development of vaccines for emerging infectious diseases. With key players like Serum Institute of India and Bharat Biotech leading the way, India is poised to become a major player in the global vaccine market.
Related Analysis: View Previous Industry Report
